The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Inflammatory bowel disease drugs global market share in 2018, by drug class
Global IBD drug market share 2018, by drug class
During 2018, biologics took up the greatest global market share at **** percent, followed by aminosalicylates with just over ** percent of the market. This statistic shows the percent distribution of the inflammatory bowel disease (IBD) drugs global market in 2018, by drug class.
Log in or register to access precise data.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Top IBD therapies by cost 2014
- Premium Statistic Generics share of prescription spending in the U.S. by formulation 2012 vs. 2017
- Basic Statistic Rates of drug shortages in Canada by manufacturer number 2019/2020
- Basic Statistic Rates of drug shortages in Canada by formulation 2019/2020
- Basic Statistic Select top diabetes drugs by sales in 2020 and 2024 forecast
- Basic Statistic Number of approved ANDAs in U.S. 2009-2023
- Basic Statistic Generics share of pharmaceutical market value in Turkey 2008-2023
- Premium Statistic Market share of generics in Finland 2016-2021
- Premium Statistic Leading MS pharmaceutical drugs in the U.S. by revenue 2013
- Premium Statistic Generic market share value change worldwide 2006 vs. 2016, by region
About the region
10
- Basic Statistic Global blood plasma market share 2017, by country
- Premium Statistic Share of global immunoglobulin therapies market 2017, by country
- Basic Statistic Per capita albumin consumption change 2012-2016, by country
- Premium Statistic Immunoglobulin utilization growth 2015-2017, by diagnosis
- Premium Statistic Total global prescription drug sales of top 10 companies 2026 projection
- Basic Statistic Beta-lactam and beta-lactamase inhibitors market worldwide 2030 forecast
- Basic Statistic Global cancer microbiome sequencing market share by application 2020 & 2031
- Basic Statistic AstraZeneca's number of animals used for research purposes 2006-2025
- Basic Statistic Global next-generation biomanufacturing market share by workflow 2020 & 2031
- Premium Statistic Immunoglobulin consumption in select countries 2017
Selected statistics
10
- Basic Statistic Pharmaceutical spending per capita in selected countries 2024
- Basic Statistic Global anti-viral market size 2019 and 2027 forecast
- Premium Statistic AstraZeneca's top products based on revenue 2024-2025
- Basic Statistic Worldwide generic prescription drug sales 2012-2026
- Premium Statistic Savings through generic drug usage in the U.S. 2008-2024
- Premium Statistic GSK Pharmaceuticals revenue 2025, by therapeutic area
- Basic Statistic Projected small molecule sales at risk due to patent expiry in the U.S. 2019-2028
- Basic Statistic Market share of generics in European countries 2024
- Basic Statistic Price disparities for top product Xarelto - U.S. and international 2025
- Premium Statistic Price disparities for top product Januvia U.S. vs international 2026
Other regions
10
- Basic Statistic Export value of pharmaceuticals from Sweden 2012-2024
- Premium Statistic Metabolic & digestive pharmaceuticals revenue in Argentina 2017-2022
- Premium Statistic Loss of Neupogen sales to U.S. biosimilars 2015-2017
- Basic Statistic Net export value of pharmaceuticals from Sweden 2012-2024
- Basic Statistic Average Parkinson's neuromodulation device price U.S. 2018, by manufacturer
- Premium Statistic Top pharmaceutical companies in Canada by market share 2023
- Premium Statistic Share of filgrastim sales attributable to Neupogen or biosimilars US 2015-2024
- Premium Statistic U.S. total vs. generic dispensed prescription numbers 2017, by formulation
- Premium Statistic Generic market share change in unit volume worldwide 2006 vs. 2016, by region
- Premium Statistic Generic share of dispensed prescriptions by formulation U.S. 2012 vs. 2017
Related statistics
10
- Premium Statistic Market share of companies in branded generic drugs Philippines 2007-2016, by type
- Premium Statistic Market share of companies in unbranded generic drugs Philippines 2007-2016, by type
- Premium Statistic Number of drug shortages in Canada in selected months 2017-2020
- Basic Statistic Distribution of reasons for drug shortages in Canada 2017-2020
- Basic Statistic Distribution of beneficiaries number for drug shortages in Canada 2017-2020
- Premium Statistic Sales growth of top pharmaceutical products in Canada 2023
- Premium Statistic Revenue of top 20 respiratory brands in the U.S. 2016
- Premium Statistic Brand and generic prescription medication spending in the U.S. 2006-2021
- Premium Statistic Canadian pharmaceutical exports and imports 2004-2024
- Premium Statistic Top ranking Colombia's pharmaceutical companies by retail market share 2017
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
BioSpace. (November 19, 2019). Inflammatory bowel disease drugs global market share in 2018, by drug class [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 21, 2026, from /statistics/1093344/ibd-drug-market-share-global-by-class/
BioSpace. "Inflammatory bowel disease drugs global market share in 2018, by drug class." Chart. November 19, 2019. ÌÇÐÄÆƽâ°æ. Accessed July 21, 2026. /statistics/1093344/ibd-drug-market-share-global-by-class/
BioSpace. (2019). Inflammatory bowel disease drugs global market share in 2018, by drug class. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 21, 2026. /statistics/1093344/ibd-drug-market-share-global-by-class/
BioSpace. "Inflammatory Bowel Disease Drugs Global Market Share in 2018, by Drug Class." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 19 Nov 2019, /statistics/1093344/ibd-drug-market-share-global-by-class/
BioSpace, Inflammatory bowel disease drugs global market share in 2018, by drug class ÌÇÐÄÆƽâ°æ, /statistics/1093344/ibd-drug-market-share-global-by-class/ (last visited July 21, 2026)
Inflammatory bowel disease drugs global market share in 2018, by drug class [Graph], BioSpace, November 19, 2019. [Online]. Available: /statistics/1093344/ibd-drug-market-share-global-by-class/
Advertisement